PopVax

About PopVax

PopVax is an Indian full-stack biotechnology company focused on developing novel mRNA vaccines and therapeutics using computational protein design. Founded in late 2021, their mission is to create population-scale vaccines, aiming to save one million lives annually from infectious diseases over the next decade by ensuring global access to cutting-edge vaccine technologies, particularly in developing regions.

Products & Services

COVID-19 Vaccine:A next-generation open-source mRNA vaccine designed to provide broader protection against current and future SARS-CoV-2 variants, showing 10-100x more potent antibody responses in preclinical studies compared to existing US-approved mRNA vaccines.

Influenza Vaccine:A seasonal influenza vaccine using a novel mRNA-encoded immunogen display architecture, delivered via a self-administered dissolvable microarray patch, with promising preclinical data.

Broadly-Protective Vaccines:Vaccines targeting groups of high-risk pathogens like Influenza and betacoronaviruses (SARS-CoV, SARS-CoV-2, MERS-CoV) to prevent future pandemics.

Vaccines for Major Diseases:Vaccines targeting Adult Pulmonary Tuberculosis, Hepatitis C, and Strep A, which cause over 2 million deaths yearly, using computational protein design and high-throughput immunology.

Vaccines for Chronic Infections:Vaccines against ubiquitous pathogens causing latent chronic infections (e.g., HPV, EBV), linked to severe long-term conditions like cervical cancer and multiple sclerosis.

Specialties

mRNA Vaccines Computational Protein Design Lipid Nanoparticle (LNP) Delivery Machine Learning in Protein Design Virus-Like Particle (VLP) Immunogen Display GMP Production Immunology Thermostable mRNA Formulations

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Grant T: - FT: Grant	A: 1150000 MR: - FA: 1.15 Million USD FAN: 1150000	D: 2024-10-30 FD: 2024-10-30	1 investors

Grant Latest

2024-10-30

$1.1M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

S

Soham Sankaran

Founder of PopVax

V

Vitalik Buterin

Recent News

PopVax Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised